Business
Adagio Medical Appoints Two Seasoned Senior Executives to Accelerate Commercial Readiness
LAGUNA HILLS, Calif., December 22, 2025--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced two key additions to its senior leadership team: Marie-Claude Jacques as Senior Vice President, Global Sales and Antwan Gipson as Senior Vice President, Manufacturing and Operations.
About this update from Adagio Medical Holdings, Inc
[{"type":"text","content":"Marie-Claude Jacques appointed Senior Vice President, Global Sales; Antwan Gipson joins as Senior Vice President, Manufacturing & Operations","length":144,"tagName":"p","attribs":{}},{"type":"text","content":"LAGUNA HILLS, Calif., December 22, 2025--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced two key additions to its senior leadership team: Marie-Claude Jacques as Senior Vice President, Global Sales and Antwan Gipson as Senior Vice President, Manufacturing and Operations.","length":446,"tagName":"p"},{"type":"text","content":""These appointments represent a significant milestone as Adagio prepares for commercialization of our proprietary Ultra-Low Temperature Cardiac Ablation technology ("ULTC") for electrophysiology ("EP")," said Todd Usen, Chief Executive Officer of Adagio Medical. "Marie-Claude is a proven commercial leader with a track record at Baylis of introducing a disruptive technology and energy source as a small entrant into the established EP market and growing these into widely adopted tools for EP, which culminated in the acquisition of Baylis by Boston Scientific. Antwan brings over two decades of leadership experience building scalable, compliant manufacturing infrastructures for energy-based and catheter-based devices in high-growth organizations. Their complementary skills will be instrumental as we prepare for the commercial launch of our ULTC ablation platform."","length":912,"tagName":"p"},{"type":"text","content":"Marie-Claude Jacques, Senior Vice President of Global Sales, brings over 15 years of commercial leadership experience across electrophysiology and interventional cardiology with deep expertise in global market development, sales force build-out, and physician adoption of novel technologies. She most recently served as Chief Commercial Officer at Catheter Precision, where she led global sales and marketing for the commercial launches of VIVO™, a non-invasive 3D mapping system, and LockeT™, a venous closure device. Previously, Ms. Jacques was Vice President of Sales and Marketing at Baylis Medical, where she built and led a 100-person organization and helped scale the company’s el...